In-depth research on T cells in TILs in breast cancer patients revealed that CD8+ T-cell infiltration has been associated with a favorable clinical outcome; however, cancer cells could develop several resistance mechanisms against CD8+ T-cell antitumor activity [18,19,20,21,22,23,24]. Here, CD8A is linked to breast carcinoma.